Abstract

Quality by Design (QbD) is a systematic approach to pharmaceutical development that emphasizes designing quality into processes from the outset rather than relying solely on end-product testing. In the field of Industrial Pharmacy, QbD is revolutionizing drug development and manufacturing by enhancing efficiency, reducing costs, and ensuring product quality. This article explores the principles of QbD, its application in drug development, and its impact on manufacturing efficiency. We discuss key elements such as critical quality attributes (CQAs), critical process parameters (CPPs), and the importance of risk management. Additionally, we examine case studies and the role of regulatory agencies in promoting QbD practices. The article concludes with insights into the future of QbD in Industrial Pharmacy, highlighting its potential to further transform the pharmaceutical industry.